syros.com (SYRS): O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Komponentlar yetkazib berishning barqarorligi va laboratoriya shartnomalari Syros Pharmaceuticals (SYRS) kompaniyasida tadqiqotlarning uzluksizligini ta'minlaydi. Tarixiy PEG darajasi ushbu ishning natijasini vizuallashtiradi, bunda ko'rsatkich 0.00 ga yetadi. Restrukturizatsiyaning yuqori shaffofligi klinik muvaffaqiyatsizliklardan keyingi mablag'larning kritik yetishmovchiligi bilan birga mavjud. Shu bilan birga, noyob patent himoyasi va bioprotsesslarning murakkabligi raqobatchilar uchun sezilarli to'siqlarni yaratadi.
Syros Pharmaceuticals (SYRS) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Syros Pharmaceuticals|SYRS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati syros.com|SYRS - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Syros|SYRS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Syros Pharmaceuticals|Tezkor likvidlik koeffitsiyenti syros.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
SYRS - Sof foyda|Kelajakdagi foyda Syros Pharmaceuticals|SYRS - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Syros Pharmaceuticals, Inc|SYRS - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Syros|SYRS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Syros Pharmaceuticals|SYRS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi syros.com|SYRS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Syros Pharmaceuticals
Kompaniyaning fundamental tahlili:Syros Pharmaceuticals Inc., SYRS
Yuqori sifatli portfelni shakllantirish uchun men PEG koeffitsiyentidan foydalanaman, u aktivning adolatli qiymatini kelajakdagi kengayishga asoslanib aniqlash uchun P/E koeffitsiyentini foyda o'sish sur'atlari bilan bog'laydi. Sog'liqni saqlash gigantlari bilan hamkorlik orqali o'z gen terapiyasi platformasini monetizatsiya qilayotgan Syros Pharmaceuticals (SYRS) uchun o'sish aksiyalarining past baholanganligi bo'yicha ushbu metrika bozor narxi va intellektual mulki potensiali o'rtasidagi tafovutni ochib beradi.
Syros Pharmaceuticals raqobatchilari
TEM - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Qiagen Group QGEN|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Isis Pharmaceuticals (IONS)|RGEN: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RNA (aviditybiosciences.com)|CRISPR Therapeutics (CRSP) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WGS (GeneDx Holdings)|RARE (Ultragenyx Pharma) - PEG multiplikatori|BEAM: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SRPT|PEG multiplikatori twistbioscience.com (TWST)|Narxning foydaga va o‘sish sur’atiga nisbati 10x Genomics TXG|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NTLA|STOK - Narxning foydaga va o‘sish sur’atiga nisbati|BioLife (BLFS) - Narx-foyda va o‘sish multiplikatori|WVE: PEG multiplikatori|mazetx.com (MAZE) - PEG multiplikatori|SION (Sionna Therapeutics) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Prime Medicine Inc (PRME)|PEG multiplikatori TSHA|QURE - O‘sish sur’atiga tuzatilgan narx-foyda|MeiraGTx Holdings plc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori regenxbio.com RGNX|SLDB: Narx-foyda va o‘sish multiplikatori|Ocugen Inc - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PACB: PEG multiplikatori|BNTC - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|DSGN (Design Therapeutics) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori rocketpharma.com (RCKT)|PEG multiplikatori FDMT|PEG multiplikatori lexeotx.com (LXEO)|Narxning foydaga va o‘sish sur’atiga nisbati Korro Bio KRRO|Editas Corp - Narxning foydaga va o‘sish sur’atiga nisbati|SLN - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati ProQR Therapeutics N.V. PRQR|codexis.com (CDXS) - Narxning foydaga va o‘sish sur’atiga nisbati|SGMO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori NAUT|O‘sish sur’atiga tuzatilgan narx-foyda Metagenomi Therapeutics MGX|Narxning foydaga va o‘sish sur’atiga nisbati Precision BioSciences (DTIL)|GBIO (generationbio.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Boundless Bio BOLD|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Exicure Inc. (XCUR)|Celsion Corporation - PEG multiplikatori|PHIO (Phio Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|mustangbio.com (MBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti RNAZ|BNGO (Bionano Genomics Inc.) - PEG multiplikatori|PEG multiplikatori Applied DNA Sciences Inc|Narxning foydaga va o‘sish sur’atiga nisbati Bluebird Bio (BLUE)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunoprecise.com|Omega Therapeutics - Narx-foyda va o‘sish multiplikatori|singulargenomics.com (OMIC) - O‘sish sur’atiga tuzatilgan narx-foyda|RGLS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TBIO (Telesis Bio Inc.)|TRACON (TCON) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Unity Biotechnology, Inc (UBX)
